advertisement
Toris CB 24
Showing records 1 to 24 |
Display all abstracts from Toris CB80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptorsColeman RA
British Journal of Pharmacology 2019; 176: 687-698
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adultsFan S
British Journal of Ophthalmology 2019; 103: 1845-1849
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodWoodward DF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptorsColeman RA
British Journal of Pharmacology 2019; 176: 687-698
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adultsGuo T
British Journal of Ophthalmology 2019; 103: 1845-1849
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptorsWoodrooffe AJ
British Journal of Pharmacology 2019; 176: 687-698
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodWang JW
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptorsWoodrooffe AJ; Clark KL
British Journal of Pharmacology 2019; 176: 687-698
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodColeman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptorsClark KL
British Journal of Pharmacology 2019; 176: 687-698
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodColeman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adultsChen B
British Journal of Ophthalmology 2019; 103: 1845-1849
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptorsToris CB
British Journal of Pharmacology 2019; 176: 687-698
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodWoodrooffe AJ; Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adultsXiong J
British Journal of Ophthalmology 2019; 103: 1845-1849
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodClark KL; Clark KL
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adultsHavens S
British Journal of Ophthalmology 2019; 103: 1845-1849
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptorsFan S; Wang JW
British Journal of Pharmacology 2019; 176: 687-698
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adultsGulati V
British Journal of Ophthalmology 2019; 103: 1845-1849
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodStamer WD
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptorsWoodward DF
British Journal of Pharmacology 2019; 176: 687-698
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodTao G
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adultsToris CB
British Journal of Ophthalmology 2019; 103: 1845-1849
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery MethodFan S; Toris CB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277